HIGHLIGHTS
- who: Xi Zhang and colleagues from the Shanghai Jiao Tong University, China have published the article: Case report: A report of the complete pathological response of intrahepatic cholangiocarcinoma after conversion therapy, in the Journal: (JOURNAL)
- what: The authors report a case of successful conversion therapy with complete pathological necrosis following treatment with cisplatin, albumin-bound paclitaxel, and gemcitabine in combination with camrelizumab. patient`s PDL1, TMB, and dMMR/MSI is currently of little relevance, so the authors did not do these tests.
SUMMARY
The average 5year overall survival of patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.